Described are gas flow disruption alarms. The alarms can include a gas inlet; a gas outlet configured to couple to a gas delivery device; and a vibration member between the gas inlet and the gas outlet configured to produce an audible sound when a gas delivery device is removed from the gas outlet.

The present invention relates to a respiratory device with a housing comprising a pneumatic unit and at least one further component, in particular a respiratory gas drive, and at least one measuring unit, and also an expiration unit, an accumulator, a control unit and a cooling fan. The pneumatic unit is designed as a pneumatic conveying line which is removable from the housing and which is formed and arranged from an appliance inlet to an appliance outlet of the housing and comprises a support frame on which are arranged at least one component, in particular the respiratory gas drive, at least one sound unit, at least one flow measurement path, at least one measuring unit and the cooling fan

An aerosol inhalation spacer for use with a metered-dose inhaler canister is disclosed. The spacer includes a transparent chamber housing having a body with an input end and an output end and defining an interior space. A mouthpiece is connected to the output end of the chamber housing. An inhaler adapter is connected to the input end of the chamber housing. A valve member is disposed between the mouthpiece and the output end of the chamber housing, the valve member includes a one-way inhalation valve and a one-way exhalation valve. A flow indicator is connected to the inhaler adapter and extends into the interior space of the chamber housing for indicating an inhalation flow rate to the user.

The present disclosure relates generally to the field of medical treatment and therapy of mammalian tissue. More specifically, it relates to coverings and/or dressings that provide negative pressure at mammalian tissue sites, such as at one or more sites of surgical, non-surgical, and/or traumatic wounds, to promote closure and healing of the wounds. A key embodiment of the disclosed invention entails the use of a dressing that comprises a sponge that is shaped so as to create a vector force inward bringing wound edges together to promote healing, especially upon application of negative pressure. Other key features of the disclosed invention are its simplicity, its low cost, and that it is completely mechanical and lacks the need for any electronic components. The disclosure also relates to devices, systems, kits and methods for providing said negative pressure at said mammalian tissue sites and promote healing.

An accessory device for delivering medications from press and breath metered-dose inhalers (pMDIs), including those medications containing hydrofluoroalkane propellants. The device includes a collapsible flexible bag to which is attached a bidirectional mouthpiece and an adaptor that receives the press and breath MDI. The mouthpiece contains a reed that functions as an audible signal, and a screen to prevent inhalation of unwanted particles. The adaptor positions the press and breath MDI at an angle to direct the aerosol spray toward the center of the collapsible flexible bag. When the press and breath MDI is triggered, it discharges the aerosolized medication into the center of the collapsible flexible bag which is then inhaled by the user through the mouthpiece. This collapses the bag. The reed emits an audible sound if the user inhales above a pre-determined flow rate to maximize medication delivery and ensure dose-to-dose consistency.

A device for targeted delivery of a substance to an airway may include a conduit and at least two applicators. The conduit may include a primal end and a bifurcated distal portion having two distal ends. Each applicator may be coupled with one of the distill ends of the conduit and may be configured to direct the substance out of the applicator toward one of two sides of an airway. A method for targeted delivery of a substance to an airway may involve advancing a substance delivery device into the airway, contacting two sides of the airway with at least two applicators of the substance delivery device, such that each applicator contacts the airway near a glossopharyngeal nerve and/or a superior laryngeal nerve on each of the two sides of the airway, and delivering the substance through the applicators to contact the airway along the two sides.

The invention relates to a drug delivery system for a patient comprising an insulin delivery device (100), a user interface (101), a controller comprising instructions and a user definable threshold criterion (114; 116) of a residual availability of a drug provided in a reservoir (102) of the drug delivery system, wherein executing of the instructions by the controller (110) causes the controller (110) to control the drug delivery system to determine the amount of the drug that is currently available to the patient and compare the determined amount with the threshold criterion (114; 116), in response to the comparison, in case the determined amount is lower than or equal to the threshold criterion (114; 116), providing a signal to the patient via the user interface (101). The drug is insulin.

A cleaning catheter (200) insertable into a tracheal ventilation tube (160) and an input module (156) are provided for use with a suction source (601), the input module (156) coupled to the cleaning catheter (200) and including (i) an inflation module (330), including an inflation chamber (335) separate from the suction source (601); (ii) a flow regulator (700), configured to assume first and second fluid-control states; and (iii) a mechanical user control element (320), which is configured (a) to mechanically and non-electrically set the fluid-control states, (b) to assume first and second configurations, and (c) to mechanically and non-electrically increase pressure in an interior of an inflation chamber (335) during a transition of the mechanical user control element (320) from the first configuration to the second configuration. The flow regulator (700), when in the first fluid-control state connects the suction source (601) and an interior of an inflatable element (588) of the cleaning catheter (200) in fluid communication to deflate the inflatable element (588).

A speech valve for placing and fitting on a tracheostomy cannula, having a throughflow body enclosing a throughflow channel which on one side at one end has a connection for joining to a proximal end of the tracheostomy cannula, a one-way valve located at an end of the throughflow body opposite the connection, and, at a distance along the throughflow channel between the connection and the one-way valve, a valve opening is located which is closable by an overpressure valve. The overpressure valve arrangement has at least one elastically deformable valve flap which, in a first state covers the valve opening provided between the connection structure and the one-way valve on the throughflow body and, at a predefinable overpressure occurring inside the throughflow channel converts, by an overpressure-driven elastic deformation of the valve flap, to a second state, in which it at least partially exposes the valve opening.

A device for targeted delivery of a substance to an airway may include a conduit and at least two applicators. The conduit may include a proximal end and a bifurcated distal portion having two distal ends. Each applicator may be coupled with one of the distal ends of the conduit and may be configured to direct the substance out of the applicator toward one of two sides of an airway. A method for targeted delivery of a substance to an airway may involve advancing a substance delivery device into the airway, contacting two sides of the airway with at least two applicators of the substance delivery device, such that each applicator contacts the airway near a glossopharyngeal nerve and/or a superior laryngeal nerve on each of the two sides of the airway, and delivering the substance through the applicators to contact the airway along the two sides.